Oscotec Inc.

Translating science into medicine
회원가입

회원가입

로그인
PRESS

NEWSROOM

Notice Press Releases Publications IR Materials
Home NEWSROOM Publications
T기본글꼴
✔ 사이트를 뷰어로 보기
List of Articles
Date Site
2018-06-03 YH25448, a 3rd Generation EGFR-TKI, in Patients with EGFR-TKI-resistant NSCLC: Phase I/II Study Results
2018-05-16 YH25448, a 3rd generation EGFR-TKI, in patients with EGFR-TKI-resistant NSCLC: Phase I/II study results
2018-04-18 YH25448, an irreversible 3rd-generation EGFR TKI, exhibits superior anticancer effects with potent brain BBB penetration in NSCLC
2017-02-16 Superior Efficacy and Selectivity of Novel Small-Molecule Kinase Inhibitors of T790M-Mutant EGFR in Preclinical Models of Lung Cancer
2016-12-07 YH25448, a highly selective 3rd generation EGFR TKI, exhibits superior survival benefit over osimertinib in mice with brain metastases of NSCLC
2016-10-01 Crystal structures of spleen tyrosine kinase in complex with novel inhibitors: structural insights for design of anticancer drugs
2015-10-15 Highly potent and selective pyrazolylpyrimidines as Syk kinase inhibitors
2014-04-03 G-749, a novel FLT3 kinase inhibitor, can overcome drug resistance for the treatment of acute myeloid leukemia
2013-07-31 Crystal Structure of Pim1 Kinase in Complex with a Pyrido[4,3-D]Pyrimidine Derivative Suggests a Unique Binding Mode
Board Pagination Prev 1 Next
/ 1
© k2s0o1d6e0s8i2g7n. ALL RIGHTS RESERVED.
서버에 요청 중입니다. 잠시만 기다려 주십시오...